BioSpace News Archive

Medical device company will pursue development of strong, biocompatible adhesive that could replace sutures and dental membranes

Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic, non-alcoholic steatohepatitis (NASH) company developing pioneering medicines designed to restore metabolic balance, today announced the publication of data in the journal Cell Reports Medicine from the Phase 1 clinical trial of efruxifermin

HeyDoctor by GoodRx has grown in-house network of providers significantly since September with over 1,000 visits a day

Rapid Technologies, a Premier ServiceNow partner, recently completed a ServiceNow modernization project for San Diego-based Sanford Burnham Prebys Medical Discovery Institute.

Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, announced the Company will release its second quarter 2020 results before the market opens on Wednesday, August 5, 2020,

Men Experience Higher Levels of Stress as Crisis Continues

[21-July-2020] OTTAWA, ON , July 21, 2020 /CNW/ - Health Canada is advising Canadians that the following hand sanitizers made with ethanol or denaturants that are not acceptable for use in hand sanitizers, may pose health risks. Denaturants are added to ethanol to make it unfit for human consumption and, therefore, to avoid the unintentional ingestion of hand sanitizers (particularly by children

Psilocybin clinical project will investigate efficacy and safety of a psychedelic compound for those under severe psychological distress from terminal illness

Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic fibrosis and other diseases caused by nonsense mutations limiting production of functional proteins, today announced that it will release its second quarter 2020 financial and operational results and host a conference call and live webcast on Thursday, August 6, 2020.

Elizabeth Lee-Lewandrowski, Ph.D., MPH, a national key opinion leader on tick-borne diseases, will discuss the findings of a national seven-year study on Lyme disease testing on a webinar she will be conducting on Thursday, July 30.